Matches in Nanopublications for { ?s ?p "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148869.RArVkbbZwsGJN5OQfTOrBjxEQg14ZfhEQpX_XH3v7PdVI130_provenance.
- NP1148871.RAm5-PHiGQS8RypcCuZMyDSCrJzjEt1DCG6uwxSahlQiI130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148871.RAm5-PHiGQS8RypcCuZMyDSCrJzjEt1DCG6uwxSahlQiI130_provenance.
- NP1148874.RAvpaFzli-G2Zn-2TXX3Oz3-9LB6zmGKFEgqgCPiJbXOQ130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148874.RAvpaFzli-G2Zn-2TXX3Oz3-9LB6zmGKFEgqgCPiJbXOQ130_provenance.
- NP605939.RAEP2yp0C-_kkQ0lm1128JqOv85tMJw5hMQhTjz7TCqLs130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605939.RAEP2yp0C-_kkQ0lm1128JqOv85tMJw5hMQhTjz7TCqLs130_provenance.
- NP781385.RAMxerqw45eJoARnIoCc4QkBQAR5bpd5RDMBeym-MDYc0130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781385.RAMxerqw45eJoARnIoCc4QkBQAR5bpd5RDMBeym-MDYc0130_provenance.
- NP873144.RAKbYa_2Cs4SI9MRL2bFCWkaPRx_RTMKU2ZzUxWYDIHjg130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873144.RAKbYa_2Cs4SI9MRL2bFCWkaPRx_RTMKU2ZzUxWYDIHjg130_provenance.
- NP1148870.RAJXK-cM0kA4DRplKH8bGEGYqcPXs3vsnmLSsksUcvBZ4130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148870.RAJXK-cM0kA4DRplKH8bGEGYqcPXs3vsnmLSsksUcvBZ4130_provenance.
- NP978478.RA98dqvNMDa7YYhyaM6TVv8frbrE-1VJwUQ9GIw1JcMT0130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978478.RA98dqvNMDa7YYhyaM6TVv8frbrE-1VJwUQ9GIw1JcMT0130_provenance.
- NP1148867.RA_NNmI7RJNsnsjAFdnHohO86H2nmFdiRM2Swdgd4WTrk130_assertion description "[Within the myeloid group, SM-MPN fared better than SM-MDS or SM-AML (p?=?0.044,).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148867.RA_NNmI7RJNsnsjAFdnHohO86H2nmFdiRM2Swdgd4WTrk130_provenance.